Results 51 to 60 of about 3,177,071 (215)

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default

open access: yesFrontiers in Psychology, 2022
The acute subjective effects of psychedelics are responsive to users’ expectations and surroundings (i.e., “set and setting”). Accordingly, a great deal of thought has gone into designing the psychosocial context of psychedelic administration in clinical
David B. Yaden   +5 more
doaj   +1 more source

Psychedelic Assisted Psychotherapy [PDF]

open access: yes, 2020
Beginning in the early 1900s, research into Psychedelic Assisted Psychotherapy (PAP) showed promising results. After psychedelics were made illegal in the early 1970s they went largely underground.
McDonough, Ross, Ferguson, Lori
core   +1 more source

Data_Sheet_2_A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.xlsx

open access: yes, 2021
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield (11803265)
core   +1 more source

Psychedelic-Assisted Psychotherapy: When Two Traditions Meet

open access: yesEuropean Psychiatry, 2022
Introduction After a long moratorium since the Controlled Substances Act was passed in 1970, there has been a resurgence of research on the potential therapeutic benefits of psychedelic (PE) compounds. It has been widely believed that the PE effect is a
E. Frecska, A. Kazai, P. Bokor
doaj   +1 more source

Data_Sheet_1_A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.pdf

open access: yes, 2021
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield (11803265)
core   +1 more source

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy

open access: yesFrontiers in Psychiatry, 2021
Mindfulness-based interventions and psychedelic-assisted therapy have been experimentally utilised in recent years as alternative treatments for various psychopathologies with moderate to great success.
Maria Eleni Eleftheriou, Emily Thomas
doaj   +1 more source

Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness [PDF]

open access: yes, 2021
Background: With support from the Radcliffe Institute for Advanced Study at Harvard University, we convened researchers representing palliative care, psychosocial oncology, spiritual care, oncology, and psychedelic-assisted therapies.
Byock, Ira   +23 more
core   +1 more source

Psychedelic-assisted therapy from a narrative therapy perspective: A map for practitioners

open access: yesInternational Journal of Narrative Therapy and Community Work
Psychedelic-assisted therapy is currently in its second wave and enjoying a renaissance of sorts. This article describes a narrative therapy–inspired approach to working therapeutically with psychedelics.
Christine Dennstedt
doaj   +1 more source

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression

open access: yesFrontiers in Pharmacology, 2022
Background: Across psychotherapeutic frameworks, the strength of the therapeutic alliance has been found to correlate with treatment outcomes; however, its role has never been formally assessed in a trial of psychedelic-assisted therapy.
Roberta Murphy   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy